Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Drug Safety|July 20, 2015
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B Watkins, James H Lewis, Neil Kaplowitz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 3, 2022
Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical TrialsDavid H Alpers, James H Lewis, Christine M Hunt, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2024
Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patientsAnna Fettiplace, John Marcinak, Michael Merz, et al.
Clinical and Translational Science|August 30, 2020
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKDJames H Lewis, Michel Jadoul, Geoffrey A Block, et al.
Drug Safety|December 4, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert ConsensusAnna Fettiplace, Arie Regev, Alexandre Kiazand, et al.
Drug Safety|February 14, 2024
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory TherapyEric B Cohen, Arie Regev, Anju Garg, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2019
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitisArie Regev, Melissa Palmer, Mark I Avigan, et al.
Cell Reports Methods|October 26, 2023
A robust pipeline for high-content, high-throughput immunophenotyping reveals age- and genetics-dependent changes in blood leukocytesThomas Liechti, Sofie Van Gassen, Margaret Beddall, et al.
Drug Safety|January 13, 2024
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI InitiativeEric B Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Gastrointestinal Endoscopy|April 30, 2002
High-resolution chromoendoscopy for classifying colonic polyps: a multicenter studyGlenn M Eisen, Christopher Y Kim, David E Fleischer, et al.
Pageof 11